UPDATE 1-Wide interest seen in Petroplus Cressier plant
View full post on Yahoo! Finance: Life Insurance Industry News
View full post on Yahoo! Finance: Life Insurance Industry News
View full post on Yahoo! Finance: Life Insurance Industry News
NEW YORK (Reuters) – New York City employers likely will add nearly 39,000 workers this year and another 50,000 in 2013, but many of those jobs will pay substantially less than the thousands of highly paid Wall Street positions being cut, accordin… View full post on Yahoo! Health News
BOSTON (Reuters) – A shortage of Adderall, which is used to treat attention deficit hyperactivity disorder, shows little sign of easing as manufacturers struggle to get enough active ingredient to make the drug and demand climbs. Adderall, a stimu… View full post on Yahoo! Health News
LONDON (Reuters) – Any number of laboratories worldwide could engineer bird flu viruses into bioterror weapons capable of causing a human pandemic, and U.S. government efforts to censor research might only increase the risk that rogue elements may… View full post on Yahoo! Health News
British scientists have made the first human embryonic stem cells of a high enough grade to use in patients and deposited them in a public stem cell bank for development in human trials by drug companies and researchers by 2014. View full post on Yahoo! Health News
As scientists struggle to find a vaccine to prevent infection with the AIDS virus, a study in mice suggests hope for a new approach — one that doctors now want to test in people. View full post on Yahoo! Health News
Mobile technologies will be increasingly deployed to enable people in Asia to monitor and manage their health, with the market expected to hit $7 billion by 2017, an industry official said. View full post on Yahoo! Health News
Mobile technologies will be increasingly deployed to enable people in Asia to monitor and manage their health, with the market expected to hit $7 billion by 2017, an industry official said. View full post on Yahoo! Health News
Pfizer Inc's Lipitor and AstraZeneca's Crestor cholesterol drugs, taken at their highest dose, safely reduced artery-clogging plaque in heart patients, according to data from a clinical trial presented on Tuesday. View full post on Yahoo! Health News
Powered by Yahoo! Answers